Skip to content
Homepage
Author:
Tenaya Therapeutics, Inc.
Posted Date:
July 14, 2026
Tenaya Therapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4)
Tenaya Therapeutics, Inc.
July 14, 2026
Tenaya Therapeutics Appoints Eric Hyllengren as Chief Financial Officer
Tenaya Therapeutics, Inc.
June 29, 2026
